Drug Profile
EU C 001
Alternative Names: EU-C-001Latest Information Update: 28 Apr 2021
Price :
$50
*
At a glance
- Originator Roche
- Developer PresSura Neuro
- Class Antidepressants; Antiemetics; Anxiolytics
- Mechanism of Action Neurokinin 1 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Brain injuries; Craniocerebral trauma
Most Recent Events
- 28 Apr 2021 No recent reports of development identified for phase-I development in Brain injuries(In volunteers) in Australia (IV, Infusion)
- 28 Dec 2019 No recent reports of development identified for phase-I development in Craniocerebral-trauma(In volunteers) in Australia (IV, Infusion)
- 28 Dec 2019 No recent reports of development identified for phase-I development in Craniocerebral-trauma(In volunteers) in Australia (PO, Tablet)